Clinical Trials Browser

Phase 1 × Melanoma Neoplasms × Dacarbazine × Clear all

NCT00516802 2009-05-15

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Phase 1 Completed

Melanoma Neoplasms